Fosaprepitant Dimeglumine Patent Expiration
Fosaprepitant Dimeglumine was first introduced by Merck And Co Inc
Fosaprepitant Dimeglumine Patents
Given below is the list of patents protecting Fosaprepitant Dimeglumine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Focinvez | US11065256 | Administration and dosage of diaminophenothiazines | Jan 11, 2039 | Steriscience |
| Focinvez | US11065265 | Compositions of fosaprepitant and methods of preparation | Jan 11, 2039 | Steriscience |
| Focinvez | US12042504 | Injectable fosaprepitant composition | Jan 11, 2039 | Steriscience |
| Emend |
US5691336 (Pediatric) | Morpholine compounds are prodrugs useful as tachykinin receptor antagonists |
Sep 04, 2019
(Expired) | Merck And Co Inc |
| Emend | US5691336 | Morpholine compounds are prodrugs useful as tachykinin receptor antagonists |
Mar 04, 2019
(Expired) | Merck And Co Inc |
| Emend | US5716942 | Treatment of migraine with morpholine tachykinin receptor antagonists |
Feb 10, 2015
(Expired) | Merck And Co Inc |
| Emend | US5512570 | Treatment of emesis with morpholine tachykinin receptor antagonists |
Mar 04, 2014
(Expired) | Merck And Co Inc |
| Emend | US5538982 | Medical use for tachykinin antagonists |
Jul 23, 2013
(Expired) | Merck And Co Inc |
| Emend | US7214692 | Medical use for tachykinin antagonists |
Sep 18, 2012
(Expired) | Merck And Co Inc |
Fosaprepitant Dimeglumine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List